Vical Incorporated

Home » Vical Incorporated

Secondary

Vical Incorporated

They research and develop biopharmaceutical products, including those based on our patented DNA delivery technologies, for the prevention and treatment of serious or life-threatening diseases.

Symbol

VICL

Last Closing Price
$1.66

Shares
10,000,000

Effective Date
November 8, 2017

Underwriters
H.C. Wainwright

To view the prospectus for Vical Incorporated, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253